{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T12:59:37Z","timestamp":1780491577860,"version":"3.54.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MOP-84206"],"award-info":[{"award-number":["MOP-84206"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007476","name":"Canadian Diabetes Association (CDA)","doi-asserted-by":"crossref","award":["OG-3-08-2543-RR"],"award-info":[{"award-number":["OG-3-08-2543-RR"]}],"id":[{"id":"10.13039\/100007476","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000241","name":"Physicians' Services Incorporated Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000241","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jdcjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Diabetes and its Complications"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.jdiacomp.2014.09.005","type":"journal-article","created":{"date-parts":[[2014,9,16]],"date-time":"2014-09-16T02:26:07Z","timestamp":1410834367000},"page":"26-31","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Erythropoietin and glucose homeostasis in women at varying degrees of future diabetic risk"],"prefix":"10.1016","volume":"29","author":[{"given":"Reema","family":"Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minna","family":"Woo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip W.","family":"Connelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J.","family":"Hanley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathew","family":"Sermer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Zinman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Retnakaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.jdiacomp.2014.09.005_bb0230","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.2337\/db13-0883","article-title":"Erythropoietin signaling: A novel regulator of white adipose tissue inflammation during diet-induced obesity","volume":"63","author":"Alnaeeli","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.jdiacomp.2014.09.005_bb0200","doi-asserted-by":"crossref","first-page":"5978","DOI":"10.1073\/pnas.87.15.5978","article-title":"Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells","volume":"87","author":"Anagnostou","year":"1990","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.jdiacomp.2014.09.005_bb0170","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1056\/NEJM199010043231418","article-title":"Erythropoietin-associated hypertension","volume":"323","author":"Baskin","year":"1990","journal-title":"New England Journal of Medicine"},{"issue":"Suppl. 1","key":"10.1016\/j.jdiacomp.2014.09.005_bb0100","first-page":"S1","article-title":"Canadian Diabetes Association 2013 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada","volume":"37","author":"Canadian Diabetes Association Clinical Practice Guidelines Expert Committee","year":"2013","journal-title":"Canadian Journal of Diabetes"},{"key":"10.1016\/j.jdiacomp.2014.09.005_bb0205","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/ajh\/6.2.103","article-title":"Intravenous erythropoietin (rHuEP0) administration increases plasma endothelin and blood pressure in hemodialysis patients","volume":"6","author":"Carlini","year":"1993","journal-title":"American Journal of Hypertension"},{"key":"10.1016\/j.jdiacomp.2014.09.005_bb0005","doi-asserted-by":"crossref","first-page":"284","DOI":"10.2174\/157339911796397820","article-title":"The extra-hematopoietic role of erythropoietin in diabetes mellitus","volume":"7","author":"Choi","year":"2011","journal-title":"Current Diabetes Reviews"},{"key":"10.1016\/j.jdiacomp.2014.09.005_bb0055","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1084\/jem.20100665","article-title":"Erythropoietin protects against diabetes through direct effects on pancreatic beta cells","volume":"207","author":"Choi","year":"2010","journal-title":"Journal of Experimental Medicine"},{"issue":"12","key":"10.1016\/j.jdiacomp.2014.09.005_bb0075","doi-asserted-by":"crossref","first-page":"e647","DOI":"10.1161\/STROKEAHA.109.564872","article-title":"Recombinant human erythropoietin in the treatment of acute ischemic stroke","volume":"40","author":"Ehrenreich","year":"2009","journal-title":"Stroke"},{"issue":"6","key":"10.1016\/j.jdiacomp.2014.09.005_bb0010","doi-asserted-by":"crossref","first-page":"e5894","DOI":"10.1371\/journal.pone.0005894","article-title":"Erythropoietin over-expression protects against diet-induced obesity in mice through increased fat oxidation in muscles","volume":"4","author":"Hojman","year":"2009","journal-title":"PloS One"},{"key":"10.1016\/j.jdiacomp.2014.09.005_bb0225","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0002-9343(93)90151-E","article-title":"Genetic disposition to hypertension facilitates blood pressure elevation in hemodialysis patients treated with erythropoietin","volume":"94","author":"Ishimitsu","year":"1994","journal-title":"American Journal of Medicine"},{"key":"10.1016\/j.jdiacomp.2014.09.005_bb0210","doi-asserted-by":"crossref","first-page":"PL253","DOI":"10.1016\/0024-3205(94)00842-6","article-title":"Direct evidence for erythropoietin-induced release of endothelin from peripheral vascular tissue","volume":"54","author":"Katoh","year":"1994","journal-title":"Life Sciences"},{"issue":"1","key":"10.1016\/j.jdiacomp.2014.09.005_bb0015","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1677\/JOE-09-0425","article-title":"Erythropoietin treatment leads to reduced blood glucose levels and body mass: Insights from murine models","volume":"205","author":"Katz","year":"2010","journal-title":"Journal of Endocrinology"},{"key":"10.1016\/j.jdiacomp.2014.09.005_bb0160","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1542-4758.2009.00367.x","article-title":"Effect of recombinant human erythropoietin on insulin resistance in hemodialysis patients","volume":"13","author":"Khedr","year":"2009","journal-title":"Hemodialysis International"},{"key":"10.1016\/j.jdiacomp.2014.09.005_bb0090","doi-asserted-by":"crossref","DOI":"10.2337\/db14-0489","article-title":"Prospective associations of vitamin D status with beta-cell function, insulin sensitivity and glycemia: The impact of parathyroid hormone status","author":"Kramer","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.jdiacomp.2014.09.005_bb0130","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.diabres.2009.01.008","article-title":"Erythropoietin during hypoglycaemia in type 1 diabetes: Relation to basal renin\u2013angiotensin system activity and cognitive function","volume":"85","author":"Kristensen","year":"2009","journal-title":"Diabetes Research and Clinical Practice"},{"issue":"4","key":"10.1016\/j.jdiacomp.2014.09.005_bb0140","doi-asserted-by":"crossref","first-page":"e59672","DOI":"10.1371\/journal.pone.0059672","article-title":"Influence of erythropoietin on cognitive performance during experimental hypoglycemia in patients with type 1 diabetes mellitus: A randomized cross-over trial","volume":"8","author":"Kristensen","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.jdiacomp.2014.09.005_bb0135","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1530\/EJE-10-0464","article-title":"Erythropoietin and vascular endothelial growth factor as risk markers for severe hypoglycaemia in type 1 diabetes","volume":"163","author":"Kristensen","year":"2010","journal-title":"European Journal of Endocrinology"},{"key":"10.1016\/j.jdiacomp.2014.09.005_bb0195","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1093\/ndt\/12.6.1155","article-title":"Is endogenous erythropoietin a pathogenetic factor in the development of essential hypertension?","volume":"12","author":"Langenfeld","year":"1997","journal-title":"Nephrology, Dialysis, Transplantation"},{"key":"10.1016\/j.jdiacomp.2014.09.005_bb0215","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1038\/ki.1989.274","article-title":"Vascular changes in hemodialysis patients in response to recombinant human erythropoietin","volume":"36","author":"London","year":"1989","journal-title":"Kidney International"},{"issue":"10","key":"10.1016\/j.jdiacomp.2014.09.005_bb0050","doi-asserted-by":"crossref","first-page":"3652","DOI":"10.1210\/en.2013-1113","article-title":"In vivo knockdown of adipocyte erythropoietin receptor does not alter glucose or energy homeostasis","volume":"154","author":"Luk","year":"2013","journal-title":"Endocrinology"},{"key":"10.1016\/j.jdiacomp.2014.09.005_bb0070","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1113\/jphysiol.2010.195917","article-title":"Effects of recombinant human erythropoietin in normal humans","volume":"589","author":"Lundby","year":"2011","journal-title":"Journal of Physiology"},{"key":"10.1016\/j.jdiacomp.2014.09.005_bb0105","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","article-title":"Insulin sensitivity indices obtained from oral glucose tolerance testing: Comparison with the euglycemic insulin clamp","volume":"22","author":"Matsuda","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2014.09.005_bb0120","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jdiacomp.2005.08.001","article-title":"Anemia and the role of erythropoietin in diabetes","volume":"20","author":"McGill","year":"2006","journal-title":"Journal of Diabetes and its Complications"},{"issue":"1","key":"10.1016\/j.jdiacomp.2014.09.005_bb0235","doi-asserted-by":"crossref","first-page":"e53557","DOI":"10.1371\/journal.pone.0053557","article-title":"Erythropoietin inhibits gluconeogenesis and inflammation in the liver and improves glucose intolerance in high-fat diet-fed mice","volume":"8","author":"Meng","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.jdiacomp.2014.09.005_bb0220","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1081\/CEH-100101998","article-title":"Chronic nitric oxide inhibition aggravates hypertension in erythropoietin-treated renal failure rats","volume":"22","author":"Moreau","year":"2000","journal-title":"Clinical and Experimental Hypertension"},{"key":"10.1016\/j.jdiacomp.2014.09.005_bb0150","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.2337\/dc10-0917","article-title":"The effect of iron and erythropoietin treatment on the A1c of patients with diabetes and chronic kidney disease","volume":"33","author":"Ng","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2014.09.005_bb0175","first-page":"76","article-title":"Effects of erythropoietin on blood pressure","volume":"18","author":"Raine","year":"1991","journal-title":"American Journal of Kidney Diseases"},{"key":"10.1016\/j.jdiacomp.2014.09.005_bb0185","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1096\/fj.11-193508","article-title":"Both acute and prolonged administration of EPO reduce cerebral and systemic vascular conductance in humans","volume":"26","author":"Rasmussen","year":"2012","journal-title":"FASEB Journal"},{"key":"10.1016\/j.jdiacomp.2014.09.005_bb0115","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1111\/j.1464-5491.2009.02841.x","article-title":"Evaluation of proposed oral disposition index measures in relation to the actual disposition index","volume":"26","author":"Retnakaran","year":"2009","journal-title":"Diabetic Medicine"},{"key":"10.1016\/j.jdiacomp.2014.09.005_bb0085","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.2337\/dc10-0351","article-title":"Beta-cell function declines within the first year postpartum in women with recent glucose intolerance in pregnancy","volume":"33","author":"Retnakaran","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2014.09.005_bb0095","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.numecd.2011.02.010","article-title":"The postpartum cardiovascular risk factor profile of women with isolated hyperglycemia at 1-hour on the oral glucose tolerance test in pregnancy","volume":"21","author":"Retnakaran","year":"2011","journal-title":"Nutrition, Metabolism, and Cardiovascular Diseases"},{"issue":"8","key":"10.1016\/j.jdiacomp.2014.09.005_bb0110","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1038\/oby.2008.307","article-title":"Hyperbolic relationship between insulin secretion and sensitivity on oral glucose tolerance test","volume":"16","author":"Retnakaran","year":"2008","journal-title":"Obesity"},{"key":"10.1016\/j.jdiacomp.2014.09.005_bb0165","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1159\/000416009","article-title":"Blood pressure changes during treatment with recombinant human erythropoietin","volume":"66","author":"Samtleben","year":"1988","journal-title":"Contributions to Nephrology"},{"key":"10.1016\/j.jdiacomp.2014.09.005_bb0190","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0272-6386(97)90198-0","article-title":"Endogenous erythropoietin correlates with blood pressure in essential hypertension","volume":"29","author":"Schmieder","year":"1997","journal-title":"American Journal of Kidney Diseases"},{"key":"10.1016\/j.jdiacomp.2014.09.005_bb0020","doi-asserted-by":"crossref","first-page":"910159","DOI":"10.1155\/2011\/910159","article-title":"A novel EPO receptor agonist improves glucose tolerance via glucose uptake in skeletal muscle in a mouse model of diabetes","volume":"2011","author":"Scully","year":"2011","journal-title":"Experimental Diabetes Research"},{"key":"10.1016\/j.jdiacomp.2014.09.005_bb0155","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1159\/000045606","article-title":"Effect of short-term rHuEPO treatment on insulin resistance in haemodialysis patients","volume":"84","author":"Spaia","year":"2000","journal-title":"Nephron"},{"key":"10.1016\/j.jdiacomp.2014.09.005_bb0180","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1159\/000417905","article-title":"Peripheral hemodynamics, blood viscosity, and the renin\u2013angiotensin system in hemodialysis patients under therapy with recombinant human erythropoietin","volume":"76","author":"Steffen","year":"1989","journal-title":"Contributions to Nephrology"},{"key":"10.1016\/j.jdiacomp.2014.09.005_bb0145","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.2337\/dc06-0845","article-title":"Adequacy of glycemic control in hemodialysis patients with diabetes","volume":"29","author":"Tascona","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2014.09.005_bb0125","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.semnephrol.2006.05.003","article-title":"The high prevalence of anemia in diabetes is linked to functional erythropoietin deficiency","volume":"26","author":"Thomas","year":"2006","journal-title":"Seminars in Nephrology"},{"issue":"12","key":"10.1016\/j.jdiacomp.2014.09.005_bb0045","doi-asserted-by":"crossref","first-page":"4122","DOI":"10.2337\/db13-0518","article-title":"PPAR\u03b1 and Sirt1 mediate erythropoietin action in increasing metabolic activity and browning of white adipocytes to protect against obesity and metabolic disorders","volume":"62","author":"Wang","year":"2013","journal-title":"Diabetes"},{"issue":"7","key":"10.1016\/j.jdiacomp.2014.09.005_bb0240","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.2337\/db14-0566","article-title":"Beyond erythropoiesis: Emerging metabolic roles of erythropoietin","volume":"63","author":"Woo","year":"2014","journal-title":"Diabetes"},{"issue":"12","key":"10.1016\/j.jdiacomp.2014.09.005_bb0080","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1007\/s00125-013-3048-0","article-title":"Longitudinal changes in insulin sensitivity and beta cell function between women with and without a history of gestational diabetes mellitus","volume":"56","author":"Xiang","year":"2013","journal-title":"Diabetologia"}],"container-title":["Journal of Diabetes and its Complications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872714002621?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872714002621?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,14]],"date-time":"2019-08-14T21:09:53Z","timestamp":1565816993000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056872714002621"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S1056872714002621"],"URL":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2014.09.005","relation":{},"ISSN":["1056-8727"],"issn-type":[{"value":"1056-8727","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Erythropoietin and glucose homeostasis in women at varying degrees of future diabetic risk","name":"articletitle","label":"Article Title"},{"value":"Journal of Diabetes and its Complications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2014.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}